ACMD Announces Decision on the Classification of Ketamine
The Advisory Council on the Misuse of Drugs (ACMD) has today (28 January 2026) published its updated harms assessment of ketamine ACMD Announces Decision on the Classification of Ketamine The ACMD has advised the government ketamine should remain a class B controlled substance, but that police forces and health care professionals must receive greater support to better identify, prevent and respond to ketamine‑related harms. In January 2025, the government asked the ACMD to review the...
